Connie M. Rhee, MD, MSc, Assistant Professor of Medicine and Public Health, Division of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, California, USAKamyar Kalantar-Zadeh, MD, MPH, PhD, Professor of Medicine, Pediatrics, Public Health, and Nursing Sciences, Division of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, California, USAGregory A. Brent, MD, Professor of Medicine and Physiology, Division of Endocrinology, Diabetes and Hypertension, David Geffen School of Medicine at the University of California Los Angeles, and Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, USA

• Section I. Diabetes, Insulin Resistance, and the Metabolic Syndrome.- Chapter 1: Insulin Resistance and the Metabolic Syndrome in Kidney Disease (e.g. the Cardiorenal Metabolic Syndrome).- Chapter 2: Diabetic Kidney Disease.- Chapter 3: Glucose Homeostasis and the Burnt-Out Diabetes Phenomenon in Patients with Kidney Disease.- Chapter 4: Glycemic Metrics and Targets in Kidney Disease.- Chapter 5: Diabetic Pharmacotherapies in Kidney Disease.- Chapter 6: Diabetes Mellitus and Renal Transplantation.- Section II. Thyroid Dysfunction.- Chapter 7: Evaluating Thyroid Function Tests in Patients with Kidney Disease.- Chapter 8: Thyroid Status and Outcomes in Kidney Disease.- Section III. Gonadal Disorders.- Chapter 9: Testosterone Deficiency and Other Testicular Disorders in Kidney Disease.- Chapter 10: Amenorrhea and Estrogen Disorders in Women with Kidney Disease.- Chapter 11: Pregnancy in Kidney Disease.- Section IV. Dyslipidemia.- Chapter 12: Lipid DisordersAssociated with Chronic Kidney Disease and Nephrotic Syndrome.- Chapter 13: Drugs for Treatment of Dyslipidemia Available in the US.- Section V. Mineral Bone Disorders.- Chapter 14: Calcium Homeostasis in Kidney Disease.- Chapter 15: Phosphorus Retention and Elevated FGF-23 in Chronic Kidney Disease.- Chapter 16: Vitamin D and Parathyroid Hormone in Kidney Disease.- Chapter 17: Management of Bone Disorders in Kidney Disease.- Chapter 18: Mineral and Bone Disorders Following Renal Transplantation.- Section VI. Obesity and Adipokines.- Chapter 19: Obeesity in Kidney Disease.- Chapter 20: Adiponectin and Leptin in Kidney Disease Patients.- Section VII. Other Pituitary Disorders.- Chapter 21: Growth Hormone Disorders and Abnormal Stature in Kidney Disease.- Chapter 22: Other Pituitary Disorders and Kidney Disease.- Chapter 23: Endocrine System in Acute Kidney Injury.- Chapter 24: Nutrition and Endocrine Disorders in Kidney Disease.

Connie M. Rhee, MD, MSc, Assistant Professor of Medicine and Public Health, Division of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, California, USAKamyar Kalantar-Zadeh, MD, MPH, PhD, Professor of Medicine, Pediatrics, Public Health, and Nursing Sciences, Division of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, California, USAGregory A. Brent, MD, Professor of Medicine and Physiology, Division of Endocrinology, Diabetes and Hypertension, David Geffen School of Medicine at the University of California Los Angeles, and Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, USA

• Section I. Diabetes, Insulin Resistance, and the Metabolic Syndrome.- Chapter 1: Insulin Resistance and the Metabolic Syndrome in Kidney Disease (e.g. the Cardiorenal Metabolic Syndrome).- Chapter 2: Diabetic Kidney Disease.- Chapter 3: Glucose Homeostasis and the Burnt-Out Diabetes Phenomenon in Patients with Kidney Disease.- Chapter 4: Glycemic Metrics and Targets in Kidney Disease.- Chapter 5: Diabetic Pharmacotherapies in Kidney Disease.- Chapter 6: Diabetes Mellitus and Renal Transplantation.- Section II. Thyroid Dysfunction.- Chapter 7: Evaluating Thyroid Function Tests in Patients with Kidney Disease.- Chapter 8: Thyroid Status and Outcomes in Kidney Disease.- Section III. Gonadal Disorders.- Chapter 9: Testosterone Deficiency and Other Testicular Disorders in Kidney Disease.- Chapter 10: Amenorrhea and Estrogen Disorders in Women with Kidney Disease.- Chapter 11: Pregnancy in Kidney Disease.- Section IV. Dyslipidemia.- Chapter 12: Lipid DisordersAssociated with Chronic Kidney Disease and Nephrotic Syndrome.- Chapter 13: Drugs for Treatment of Dyslipidemia Available in the US.- Section V. Mineral Bone Disorders.- Chapter 14: Calcium Homeostasis in Kidney Disease.- Chapter 15: Phosphorus Retention and Elevated FGF-23 in Chronic Kidney Disease.- Chapter 16: Vitamin D and Parathyroid Hormone in Kidney Disease.- Chapter 17: Management of Bone Disorders in Kidney Disease.- Chapter 18: Mineral and Bone Disorders Following Renal Transplantation.- Section VI. Obesity and Adipokines.- Chapter 19: Obeesity in Kidney Disease.- Chapter 20: Adiponectin and Leptin in Kidney Disease Patients.- Section VII. Other Pituitary Disorders.- Chapter 21: Growth Hormone Disorders and Abnormal Stature in Kidney Disease.- Chapter 22: Other Pituitary Disorders and Kidney Disease.- Chapter 23: Endocrine System in Acute Kidney Injury.- Chapter 24: Nutrition and Endocrine Disorders in Kidney Disease.

Connie M. Rhee, MD, MSc, Assistant Professor of Medicine and Public Health, Division of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, California, USAKamyar Kalantar-Zadeh, MD, MPH, PhD, Professor of Medicine, Pediatrics, Public Health, and Nursing Sciences, Division of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, California, USAGregory A. Brent, MD, Professor of Medicine and Physiology, Division of Endocrinology, Diabetes and Hypertension, David Geffen School of Medicine at the University of California Los Angeles, and Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, USA

• Section I. Diabetes, Insulin Resistance, and the Metabolic Syndrome.- Chapter 1: Insulin Resistance and the Metabolic Syndrome in Kidney Disease (e.g. the Cardiorenal Metabolic Syndrome).- Chapter 2: Diabetic Kidney Disease.- Chapter 3: Glucose Homeostasis and the Burnt-Out Diabetes Phenomenon in Patients with Kidney Disease.- Chapter 4: Glycemic Metrics and Targets in Kidney Disease.- Chapter 5: Diabetic Pharmacotherapies in Kidney Disease.- Chapter 6: Diabetes Mellitus and Renal Transplantation.- Section II. Thyroid Dysfunction.- Chapter 7: Evaluating Thyroid Function Tests in Patients with Kidney Disease.- Chapter 8: Thyroid Status and Outcomes in Kidney Disease.- Section III. Gonadal Disorders.- Chapter 9: Testosterone Deficiency and Other Testicular Disorders in Kidney Disease.- Chapter 10: Amenorrhea and Estrogen Disorders in Women with Kidney Disease.- Chapter 11: Pregnancy in Kidney Disease.- Section IV. Dyslipidemia.- Chapter 12: Lipid DisordersAssociated with Chronic Kidney Disease and Nephrotic Syndrome.- Chapter 13: Drugs for Treatment of Dyslipidemia Available in the US.- Section V. Mineral Bone Disorders.- Chapter 14: Calcium Homeostasis in Kidney Disease.- Chapter 15: Phosphorus Retention and Elevated FGF-23 in Chronic Kidney Disease.- Chapter 16: Vitamin D and Parathyroid Hormone in Kidney Disease.- Chapter 17: Management of Bone Disorders in Kidney Disease.- Chapter 18: Mineral and Bone Disorders Following Renal Transplantation.- Section VI. Obesity and Adipokines.- Chapter 19: Obeesity in Kidney Disease.- Chapter 20: Adiponectin and Leptin in Kidney Disease Patients.- Section VII. Other Pituitary Disorders.- Chapter 21: Growth Hormone Disorders and Abnormal Stature in Kidney Disease.- Chapter 22: Other Pituitary Disorders and Kidney Disease.- Chapter 23: Endocrine System in Acute Kidney Injury.- Chapter 24: Nutrition and Endocrine Disorders in Kidney Disease.